Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Markus Büchler"'
Autor:
Anastasia Lemekhova, Daniel Hornuss, Georgios Polychronidis, Philipp Mayer, Christian Rupp, Thomas Longerich, Karl-Heinz Weiss, Markus Büchler, Arianeb Mehrabi, Katrin Hoffmann
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Clinicopathological features and surgical outcomes of patients with fibrolamellar hepatocellular carcinoma (FL-HCC) are underreported. The aim of this study is to describe clinical characteristics and surgical outcomes for patient
Externí odkaz:
https://doaj.org/article/22afb35c804e4c0eb4690735e504c063
Publikováno v:
Annals of Gastroenterological Surgery, Vol 3, Iss 5, Pp 464-475 (2019)
Abstract Pancreatic cancer remains a therapeutic challenge. Surgical resection in combination with systemic chemotherapy is the only option promising long‐term survival and potential cure. However, only about 20% of patients are diagnosed with tumo
Externí odkaz:
https://doaj.org/article/8f5fa257a1524a38b6deaa348b7e732b
Autor:
P Sivaramakrishna Rachakonda, Andrea S Bauer, Huaping Xie, Daniele Campa, Cosmeri Rizzato, Federico Canzian, Stefania Beghelli, William Greenhalf, Eithne Costello, Michaela Schanne, Anette Heller, Aldo Scarpa, John P Neoptolemos, Jens Werner, Markus Büchler, Jörg D Hoheisel, Kari Hemminki, Nathalia Giese, Rajiv Kumar
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e60870 (2013)
KRAS mutations are major factors involved in initiation and maintenance of pancreatic tumors. The impact of different mutations on patient survival has not been clearly defined. We screened tumors from 171 pancreatic cancer patients for mutations in
Externí odkaz:
https://doaj.org/article/c15defcb1b3b44cb9aebfc5a3add6314
Autor:
Christof Winter, Glen Kristiansen, Stephan Kersting, Janine Roy, Daniela Aust, Thomas Knösel, Petra Rümmele, Beatrix Jahnke, Vera Hentrich, Felix Rückert, Marco Niedergethmann, Wilko Weichert, Marcus Bahra, Hans J Schlitt, Utz Settmacher, Helmut Friess, Markus Büchler, Hans-Detlev Saeger, Michael Schroeder, Christian Pilarsky, Robert Grützmann
Publikováno v:
PLoS Computational Biology, Vol 8, Iss 5, p e1002511 (2012)
Predicting the clinical outcome of cancer patients based on the expression of marker genes in their tumors has received increasing interest in the past decade. Accurate predictors of outcome and response to therapy could be used to personalize and th
Externí odkaz:
https://doaj.org/article/62632a3a8c0343be8f02bd4e0e2a108d
Autor:
Andrea S Bauer, Andreas Keller, Eithne Costello, William Greenhalf, Melanie Bier, Anne Borries, Markus Beier, John Neoptolemos, Markus Büchler, Jens Werner, Nathalia Giese, Jörg D Hoheisel
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34151 (2012)
A solid process for diagnosis could have a substantial impact on the successful treatment of pancreatic cancer, for which currently mortality is nearly identical to incidence. Variations in the abundance of all microRNA molecules from peripheral bloo
Externí odkaz:
https://doaj.org/article/985d6fe8db0d4ba8ab7e9806fae09b86
Publikováno v:
Canadian Journal of Gastroenterology, Vol 7, Iss 6, Pp 493-497 (1993)
Externí odkaz:
https://doaj.org/article/41a04eb97e0f42649a3cd8c8a2bb257b
Autor:
Mohammad Golriz, Ali Ramouz, Sadeq Ali-Hasan-Al-Saegh, Saeed Shafiei, Ehsan Aminizadeh, Ahmed Hammad, Markus Mieth, Christian Rupp, Christoph Springfeld, Katrin Hoffmann, Markus Büchler, Arianeb Mehrabi
Publikováno v:
Journal of Hepatocellular Carcinoma. 9:1137-1147
Mohammad Golriz,1,2 Ali Ramouz,1 Sadeq Ali-Hasan-Al-Saegh,1 Saeed Shafiei,1 Ehsan Aminizadeh,1 Ahmed Hammad,1 Markus Mieth,1 Christian Rupp,2,3 Christoph Springfeld,2,4 Katrin Hoffmann,1,2 Markus Büchler,1 Arianeb Mehrabi1,2 1Department of General,
Autor:
Joachim Thiery, Markus Büchler, Johann Hauss, Christof Schütte, Arved Weimann, Helmut Witzigmann, Tim Conrad, Klaus Felix, Uta Ceglarek, Sven Baumann, Julia Kase, Alexander Benedikt Leichtle, Georg Martin Fiedler
Purpose: Mass spectrometry–based serum peptidome profiling is a promising tool to identify novel disease-associated biomarkers, but is limited by preanalytic factors and the intricacies of complex data processing. Therefore, we investigated whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ae188c78bc1d63e01fa50741385a09
https://doi.org/10.1158/1078-0432.c.6516831.v1
https://doi.org/10.1158/1078-0432.c.6516831.v1
Autor:
Joachim Thiery, Markus Büchler, Johann Hauss, Christof Schütte, Arved Weimann, Helmut Witzigmann, Tim Conrad, Klaus Felix, Uta Ceglarek, Sven Baumann, Julia Kase, Alexander Benedikt Leichtle, Georg Martin Fiedler
Supplementary Data from Serum Peptidome Profiling Revealed Platelet Factor 4 as a Potential Discriminating Peptide Associated with Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff2ce979b74f03ccccd95a16b31f31c
https://doi.org/10.1158/1078-0432.22439346
https://doi.org/10.1158/1078-0432.22439346
Autor:
Peter Bailey, Xu Zhou, Jingyu An, Teresa Peccerella, Kai Hu, Christoph Springfeld, Markus Büchler, John P Neoptolemos
Publikováno v:
Function. 4
Pancreatic cancer is one of the most lethal cancers worldwide, most notably in Europe and North America. Great strides have been made in combining the most effective conventional therapies to improve survival at least in the short and medium term. Th